Results 261 to 270 of about 965,308 (338)

Epidemiology and healthcare access inequities in diabetic foot disease: a retrospective study in Central Queensland, Australia. [PDF]

BMJ Open
Soonarane YK, Kirk M, Khandaker G, Varrall R.   +3 more
europepmc   +1 more source

Design and Development of rGO and Polymer‐Based Patches for Cardiac Tissue Engineering

Journal of Applied Polymer Science, EarlyView.
ABSTRACT Myocardial infarction (MI), caused by coronary artery blockage, is a leading cause of death worldwide and results in permanent heart damage. Current treatments have limited success in fully restoring cardiac function, leading to increased interest in tissue engineering solutions.
Israa F. Abdulazez, Busra Oktay, Hilal Yilmaz, Ayse Betul Bingol, Alpay Kose, Ilkay Şenel, Eray Altan, Cem Bülent Üstündağ   +7 more
wiley   +1 more source

A comprehensive characterization of metabolic signatures-hypoxia, glycolysis, and lactylation-in non-healing diabetic foot ulcers. [PDF]

Front Mol Biosci
Hu B, Li X, Li Y, Chai S, Jin M, Zhang L.   +5 more
europepmc   +1 more source

Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis

, 2001
É. Senneville
openalex   +1 more source

Gout and NLRP3 Inflammasome Biology

Arthritis &Rheumatology, EarlyView.
This review describes the three broad stages of acute inflammation in the context of gout: initiation, leucocyte mobilization, and self‐resolution. A typical case of a gout flare is presented. The role of the NLRP3 inflammasome in acute monosodium urate crystal–induced inflammation is reviewed in detail.
Raewyn Poulsen, Nicola Dalbeth
wiley   +1 more source

Application of Carbon Nanotube-Based Elastomeric Matrix for Capacitive Sensing in Diabetic Foot Orthotics. [PDF]

Micromachines (Basel)
Elumalai M, Childs A, Williams S, Arguello G, Martinez E, Easterling A, Luis DS, Rajaraman S, Didier CM.   +8 more
europepmc   +1 more source

Skin temperature in the neuropathic diabetic foot

, 2001
Edward J. Boyko, Jessie H. Ahroni, Victoria L Stensel   +2 more
openalex   +2 more sources

Probability of pharmacokinetic/pharmacodynamic target attainment for different piperacillin/tazobactam dosing regimens in renally impaired patients in a non‐intensive care unit setting

British Journal of Clinical Pharmacology, EarlyView.
Aims To optimize antibiotic therapy for pathogens classified as susceptible, increased exposure (I), an increased exposure of piperacillin/tazobactam (PTZ) is required. However, dosing recommendations are currently only available for patients with normal renal function.
Emma Dohmann, Stefan Hagel, Max Kurlbaum, Paul Schellong, Oliver Scherf‐Clavel, Güzin Surat   +5 more
wiley   +1 more source

Bacteriological Profile and Antibiotic Susceptibility in Patients With Diabetic Foot Infections. [PDF]

Cureus
Copari-Vargas E, Copari-Vargas LE, Copari-Vargas TL, Domínguez-Valdez LF, Copari-Jimenez E, Urquizo-Ayala JG.   +5 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source